UK Nanomedicine Market Growth Factors

The UK Nanomedicine market is anticipated to grow significantly at a CAGR of 10.7% over the forecast period (2021-2027). The key aspect that drives the growth of the UK nanomedicine market is the expected developments in nanorobotics owing to the rise in funding from government organizations such as the British Society for Nanomedicines and others. Besides, the well-established healthcare infrastructure in the country in the European region, rise in the prevalence of various diseases along with the need for the development of advanced and effective treatment for these diseases is also one of the major factors driving the growth of the UK nanomedicine market over the forecast period. 

Browse the full report description UK Nanomedicines Market Size, Share & Trends Analysis Report By Indication Type (Cardiovascular Diseases, Neurological Diseases, Infectious Diseases, Oncological Diseases, Orthopedic Diseases, and Other Diseases (Urological Disease, Ophthalmic Diseases)), and by Application (Drug Delivery, Active Implants, Vaccines, Diagnostic Imaging, Biomaterials, Regenerative Medicines, and Other Applications (Tissue Regeneration)) Forecast, 2021-2027 at https://www.omrglobal.com/industry-reports/uk-nanomedicines-market

A significant prevalence of CVDs has been witnessed in the country. According to the British Heart Foundation, more than one-fourth of the fatalities in the UK occur due to CVDs, and it is responsible for around 1.6 million fatalities each year. Moreover, more than 7 million people live with one or the other type of heart disease in the UK in 2018. The rise in the aging population is increasing the prevalence rate of CVDs including stroke and other heart diseases. Hence, the rise in cardiovascular diseases demands the proper treatment, thereby, drives the growth of the UK nanomedicine market in the country over the forecast period.

Market Coverage

• Market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- By Indication Type and By Applications
• Country Covered- The UK
• Competitive Landscape- 3M Co., Johnson & Johnson Services Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca Plc., Celgene Corp., Pfizer Inc., Sanofi SA, and Smith & Nephew Plc among others

Key questions addressed by the report

• What is the market growth rate?
• Which segment dominates the market in base year?
• Which segment will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

UK Nanomedicine Market – Segmentation

By Indication Type

• Cardiovascular Diseases
• Neurological Diseases
• Infectious Diseases
• Oncological Diseases
• Orthopedic Diseases
• Other Diseases (Urological Disease, Ophthalmic Diseases)

By Application

• Drug Delivery
• Active Implants
• Vaccines
• Diagnostic Imaging
• Biomaterials
• Regenerative Medicines
• Other Applications (Tissue Regeneration)